Summary: The article discusses the potential approval of MDMA for treating posttraumatic stress disorder (PTSD) in the United States based on positive results from clinical trials. If approved, this could mark a significant shift in psychiatric treatment, potentially opening the door for other psychedelic substances and offering new hope for patients with mental health disorders.